Maria C. Moretti
Foggia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Intimacy, Sexuality, and Cognitive Decline in Older Adults With Mild Neurocognitive Disorder and Mild-Stage Major Neurocognitive Disorder.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Published: May 24, 2026
Cognitive and structural brain changes in ofatumumab-treated multiple sclerosis: A longitudinal study.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 24, 2026
Transitioning from intravenous to subcutaneous ocrelizumab in a high-volume infusion center: A time-and-motion-informed capacity and service-flow analysis.
Journal: Multiple sclerosis and related disorders
Published: December 09, 2025
The epigenetic mechanisms of ketamine in the treatment of depression: a systematic review.
Journal: Epigenomics
Published: November 07, 2025
Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study.
Journal: Frontiers in immunology
Published: August 18, 2025
Corrigendum to "Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence" [Biomed. Pharmacother. 188 (2025) 118199].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 13, 2025
Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's disease.
Journal: Expert opinion on biological therapy
Published: February 05, 2025
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders.
Journal: Neural regeneration research
Published: October 21, 2024
Association of Loneliness with Functional and Cognitive Status in Minor and Major Neurocognitive Disorders.
Journal: Life (Basel, Switzerland)
Published: August 26, 2024
Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review.
Journal: Journal of clinical medicine
Published: May 31, 2023
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience.
Journal: Current neuropharmacology
Published: April 07, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026